FDA issued a Warning Letter to Agila Specialties Private Limited on 9/9/2013 for a previous inspection.
483 Mylan Labs Limited, Speciality Formulation Facility Mar 2018

483 Mylan Labs Limited, Speciality Formulation Facility Mar 2018

Yasamin Ameri FDA$119.00 - Available Now

FDA investigators audited the Mylan Labs Limited, Speciality Formulation Facility - Bangalore, India facility and issued inspectional observations (via FDA 483) on 02 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Mar 2018
  • Location: Bangalore, India
  • FEI: 3007648351
Add To Cart